Annual progress reports
Countries no longer submit annual progress reports. Please refer to the joint appraisal report and Multi-Stakeholder Dialogue documents on this page.
Annual progress report Indonesia 2007
Annual progress report Indonesia 2014
Annual progress report Indonesia 2006
Annual progress report Indonesia 2013
Annual progress report Indonesia 2004
Annual progress report Indonesia 2012
Annual progress report Indonesia 2005
Annual progress report Indonesia 2011
Annual progress report Indonesia 2003
Annual progress report Indonesia 2010
Annual progress report Indonesia 2002
Annual progress report Indonesia 2009
Annual progress report Indonesia 2001
Annual Progress Report Indonesia 2008
The joint appraisal report and Multi-Stakeholder Dialogue
The joint appraisal is an in-country, multi-stakeholder review of the implementation progress and performance of Gavi's vaccine and cash grant support to the country, and of its contribution to improved immunisation outcomes. The outcome of the appraisal is the completed "joint appraisal report" that captures Gavi grant performance as well as implementation challenges. The joint appraisal report informs discussions with national coordination mechanisms on areas where greater national investments and efforts, as well as technical support, are needed.
In 2020/2021, as a result of the COVID-19 pandemic, Multi-stakeholder dialogue (MSD) documents temporarily replaced the traditional Joint Appraisal to ensure that Gavi’s continuing support to the EPI programme be aligned with realities at country level.
Proposal for HPV Demo support: Indonesia
Proposal for NVS - JE, MR support: Indonesia
Proposal for NVS - IPV support 2016: Indonesia
Proposal for NVS - Penta support: Indonesia
Proposal for ISS support: Indonesia
Proposal for CSO support: Indonesia
Proposal for HSS support: Indonesia
Proposal for ISS support: Indonesia (2003)
Proposal and clarifications for NVS - HepB support: Indonesia
Comprehensive multi-year plans, Financial sustainability plans, National Immunisation Strategy
The comprehensive multi-year plan (cMYP) is a single plan which consolidates several immunisation activities. It is a key planning and management tool for national immunisation programmes. It addresses global, national, and subnational immunisation objectives and strategies, and evaluates the costs and financing of the programme in line with the WHO-UNICEF Global Immunization Vision and Strategy 2006-2015. Gavi requires countries to submit a cMYP along with the standard proposal form when applying for Gavi support (ISS, INS, and NVS). In 2006, over 50 countries had developed cMYPs using the WHO-UNICEF cMYP guidelines and costing tool.
The cMYP replaces the financial sustainability plan (FSP), used to assess the funding challenges of a country's national immunisation programme within the broader health financing context and to describe the government’s approach to mobilising and effectively using resources to support medium- and long-term immunisation objectives.
Comprehensive multi-year plan for -2010-2014
Country co-financing information sheet
The country-specific co-financing sheets provide up-to-date information on countries’ eligibility status, co-financing fulfilment and requirements. They also give a summary of government health expenditure, including immunisation financing.
Specifically, the sheets provide a history of the Gavi-supported vaccines introduced per country, the country’s co-financing payments to date and its co-financing requirements for the current year. In case the country has defaulted on its co-financing requirements, there is an overview of the co-financing arrears of the previous year. Finally, the sheets provide co-financing projections for the next five years based on our latest forecasts.
The information sheets are updated at least twice per year to account for new information on countries’ co-financing fulfilment (in the first quarter) and eligibility status (in the third quarter).
Co-financing information sheet Indonesia
Decision Letters and Partnerships Agreement
The Decision Letter or Partnership Framework Agreement provides a summary of the details of the new approval or continuation of a Gavi window of support, following the independent review of a new application or annual progress report submitted by a country.
Decision Letter IPV Indonesia 2020
Decision Letter ISD Indonesia 2019
Decision Letter IPV Indonesia 2019
Decision Letter NVS Indonesia 2017
Decision Letter HSS Indonesia 2015
Decision Letter - Indonesia HPV Devices Year 2
Decision Letter NVS Indonesia 2016 (5)
Partnership Framework Agreement Indonesia
Decision Letter NVS Indonesia 2018
Decision Letter NVS Indonesia 2016 (6)
Decision letter NVS Indonesia 2014(2)
Decision Letter Devices Indonesia 2017 (3)
Decision Letter NVS Indonesia 2016 (4)
Decision Letter NVS Indonesia 2014
Decision Letter NVS Indonesia 2017 (3)
Decision Letter NVS Indonesia 2016 (3)
Decision letter NVS Indonesia 2013
Decision Letter Devices Indonesia 2017 (2)
Decision Letter NVS Indonesia 2016 (2)
Decision letter HSS Indonesia 2013
Decision Letter NVS Indonesia 2017 (2)
Decision Letter NVS Indonesia 2016
Decision letter NVS Indonesia 2013 (2)
Decision Letter Devices Indonesia 2017
Decision letter NVS Indonesia 2015
Targeted country assistance plans
Targeted country assistance (TCA) are resources provided to in-country partners under Gavi’s partners’ engagement framework (PEF). A country’s TCA plan is based on needs expressed by the country during the joint appraisal discussions. It includes sets of activities, milestones and budget for a given year.